HIGHLIGHTS
- who: COPYRIGHT and colleagues from the University Belfast, United Kingdom have published the research work: Current landscape of personalized clinical treatments for triple-negative breast cancer, in the Journal: (JOURNAL)
- what: Although this studies have all made some research progress, they are still challenging at this time. At present, the main focus of existing studies is on the ongoing and completed early trials, the efficacy outcomes and common adverse events of each type of treatment, and to guide the adjustment and protocol involved in subsequent drug therapy Multicenter, long-follow, large-cohort clinical treatment investigation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.